Canada markets closed

XTL Biopharmaceuticals Ltd. (XTLB)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.8000+0.2000 (+7.69%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
-
Operating Expenses
Research Development
24
31
30
30
38
-
Selling General and Administrative
665
734
850
1,001
910
-
Total Operating Expenses
689
765
880
1,031
948
-
Operating Income or Loss
-689
-765
-880
-1,031
-948
-
Interest Expense
-
-
-
-
-
29
Total Other Income/Expenses Net
267
-1,054
-493
1,479
-2,022
-
Income Before Tax
-378
-1,782
-1,348
435
-2,954
-
Income from Continuing Operations
-378
-1,782
-1,348
435
-2,954
-
Net Income
-378
-1,782
-1,348
435
-2,954
-
Net Income available to common shareholders
-378
-1,782
-1,348
435
-2,954
-
Basic EPS
-0.40
-
-0.20
0.10
-0.60
-0.10
Diluted EPS
-0.40
-
-0.20
-0.04
-0.60
-0.10
Basic Average Shares
5,449
-
5,449
5,320
5,142
5,142
Diluted Average Shares
5,449
-
5,449
6,155
5,142
5,142